Detalles de la búsqueda
1.
Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells.
J Biol Inorg Chem
; 28(8): 751-766, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37955736
2.
In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel.
Int J Mol Sci
; 22(6)2021 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33809553
3.
Analogs of a Natural Peptaibol Exert Anticancer Activity in Both Cisplatin- and Doxorubicin-Resistant Cells and in Multicellular Tumor Spheroids.
Int J Mol Sci
; 22(16)2021 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34445069
4.
CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth.
Haematologica
; 104(3): 564-575, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30309853
5.
Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It.
Int J Mol Sci
; 20(10)2019 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31096713
6.
In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability.
Haematologica
; 107(1): 287-291, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34498447
7.
In ovarian cancer maraviroc potentiates the antitumoral activity and further inhibits the formation of a tumor-promoting microenvironment by trabectedin.
Biomed Pharmacother
; 172: 116296, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382330
8.
Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.
J Cell Biochem
; 114(5): 1135-44, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23192362
9.
Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Gynecol Oncol
; 131(3): 744-52, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24029417
10.
In Doxorubicin-Adapted Hodgkin Lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869.
Cells
; 12(23)2023 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38067159
11.
Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma.
Blood
; 126(11): 1394-7, 2015 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26228484
12.
Current and Emerging Approaches to Study Microenvironmental Interactions and Drug Activity in Classical Hodgkin Lymphoma.
Cancers (Basel)
; 14(10)2022 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35626032
13.
Design, Synthesis, and Preclinical Activity in Ovarian Cancer Models of New Phosphanegold(I)-N-heterocyclic Carbene Complexes.
J Med Chem
; 65(21): 14424-14440, 2022 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36278959
14.
IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion.
Br J Haematol
; 152(2): 182-90, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21114485
15.
Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma.
Cancer Lett
; 500: 182-193, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33326840
16.
Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance.
Pharmaceutics
; 12(5)2020 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32349462
17.
The CCL5/CCR5 Axis in Cancer Progression.
Cancers (Basel)
; 12(7)2020 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32630699
18.
Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives.
Cancers (Basel)
; 11(4)2019 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30987271
19.
Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.
Oncotarget
; 8(26): 42926-42938, 2017 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28477013
20.
New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
Oncotarget
; 8(1): 490-505, 2017 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27888799